6th Mar 2015 07:00
Venn Life Sciences Holdings Plc
("Venn" or the "Company")
Change of Registered Office
Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces that, the location of its registered office has changed to: 1 Berkeley Street, London, W1J 8DJ.
Enquiries:
Venn Life Sciences Holdings Plc | www.vennlifesciences.com |
Tony Richardson, Chief Executive Officer | Tel: +353 154 99 341 |
Orla McGuinness | Tel: +353 1 30826707
|
|
|
Zeus Capital Limited (Nominated Adviser and Broker) |
|
Ross Andrews/Andrew Jones | Tel: 0161 831 1512 |
Dominic Wilson | Tel: 020 7533 7727
|
|
|
Walbrook PR Ltd | Tel: 020 7933 8787 or [email protected] |
Paul McManus | Mob: 07980 541 893 |
Lianne Cawthorne | Mob: 07584 391 303 |
About Venn Life Sciences Limited
Venn Life Sciences is a Clinical Research Organisation providing clinical trial management solutions and resourcing solutions to pharmaceutical, biotechnology and medical device organisations. With dedicated operations in France, Germany, the Netherlands, the UK and Ireland and Europe wide representation - Venn specialises in rapid deployment and management of multisite projects. Venn recently established an innovation division - Innovenn - focused primarily on breakthrough development opportunities in Skin Science.
Related Shares:
ORPH.L